Dev Samarasinghe

2.8k total citations · 1 hit paper
22 papers, 2.3k citations indexed

About

Dev Samarasinghe is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Dev Samarasinghe has authored 22 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Dev Samarasinghe's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (6 papers). Dev Samarasinghe is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (6 papers). Dev Samarasinghe collaborates with scholars based in Australia, New Zealand and Sri Lanka. Dev Samarasinghe's co-authors include Geoffrey C. Farrell, Rita Lin, Christopher Liddle, Shivakumar Chitturi, Jacob George, Martin Weltman, Jason M. Hui, Shehan Abeygunasekera, Rooshdiya Z. Karim and Caroline Fung and has published in prestigious journals such as Hepatology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Dev Samarasinghe

20 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

2002 936 citations Shivakumar Chitturi, Shehan Abeygunasekera et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dev Samarasinghe Australia	14	2.0k	1.0k	706	339	248	22	2.3k
Rita Lin Australia	16	1.9k 1.0×	985 1.0×	699 1.0×	296 0.9×	237 1.0×	22	2.2k
Miguel Carneiro de Moura Portugal	21	2.0k 1.0×	1.1k 1.1×	680 1.0×	295 0.9×	367 1.5×	73	2.6k
A. M.‐L. Chim Hong Kong	21	2.5k 1.3×	1.7k 1.7×	594 0.8×	266 0.8×	251 1.0×	34	2.6k
Kittichai Promrat United States	16	2.4k 1.2×	1.2k 1.2×	1.1k 1.6×	340 1.0×	311 1.3×	34	2.8k
Janet C. Shaw United States	7	1.9k 1.0×	825 0.8×	855 1.2×	496 1.5×	338 1.4×	9	2.4k
Sherif Saadeh United States	10	2.0k 1.0×	1.1k 1.1×	784 1.1×	370 1.1×	333 1.3×	11	2.2k
Sushma Saksena United Kingdom	10	2.4k 1.2×	1.5k 1.5×	866 1.2×	495 1.5×	365 1.5×	22	2.6k
Terese Haaland Norway	15	1.2k 0.6×	623 0.6×	437 0.6×	368 1.1×	134 0.5×	17	1.7k
Sanne Dam‐Larsen Denmark	9	2.7k 1.4×	1.5k 1.5×	1.1k 1.5×	391 1.2×	492 2.0×	15	2.9k
Joel Z. Stengel United States	5	1.6k 0.8×	702 0.7×	688 1.0×	299 0.9×	274 1.1×	6	1.9k

Countries citing papers authored by Dev Samarasinghe

Since Specialization

Citations

This map shows the geographic impact of Dev Samarasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dev Samarasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dev Samarasinghe more than expected).

Fields of papers citing papers by Dev Samarasinghe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dev Samarasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dev Samarasinghe. The network helps show where Dev Samarasinghe may publish in the future.

Co-authorship network of co-authors of Dev Samarasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of Dev Samarasinghe. A scholar is included among the top collaborators of Dev Samarasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dev Samarasinghe. Dev Samarasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Samarasinghe, Dev, et al.. (2014). Meckel Gruber syndrome - a single gene cause of recurrent neural tube defects. Ceylon Medical Journal. 46(1). 30–30.

Nguyen, Vi, Änne Glass, Scott A. Davison, et al.. (2014). Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. Journal of Hepatology. 61(3). 502–507. 125 indexed citations

Nguyen, Van Phuong, Scott A. Davison, Dev Samarasinghe, et al.. (2014). Anti‐viral therapy for prevention of perinatalHBVtransmission: extending therapy beyond birth does not protect against post‐partum flare. Alimentary Pharmacology & Therapeutics. 39(10). 1225–1234. 82 indexed citations

Sud, Archana, Jason M. Hui, Geoffrey C. Farrell, et al.. (2004). Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology. 39(5). 1239–1247. 139 indexed citations

Byth, Karen, Rita Lin, Martin Weltman, et al.. (2004). Effects of Interferon Treatment Response on Liver Complications of Chronic Hepatitis C: 9-year Follow-Up Study. The American Journal of Gastroenterology. 99(4). 636–644. 46 indexed citations

Samarasinghe, Dev, Rita Lin, James G. Kench, et al.. (2003). Changes in Antipyrine Clearance and Platelet Count, But Not Conventional Liver Tests, Correlate With Fibrotic Change in Chronic Hepatitis C: Value for Predicting Fibrotic Progression. The American Journal of Gastroenterology. 98(6). 1384–1390. 23 indexed citations

Kumar, Dinesh, Craig T. Wallington‐Beddoe, Jacob George, et al.. (2003). Effectiveness of interferon alfa‐2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting. The Medical Journal of Australia. 178(6). 267–271. 18 indexed citations

Hui, Jason M., James G. Kench, Geoffrey C. Farrell, et al.. (2002). Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection. Journal of Gastroenterology and Hepatology. 17(8). 873–881. 140 indexed citations

Chitturi, Shivakumar, Shehan Abeygunasekera, Geoffrey C. Farrell, et al.. (2002). NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 35(2). 373–379. 936 indexed citations breakdown →

10.

Chitturi, Shivakumar, Martin Weltman, Geoffrey C. Farrell, et al.. (2002). HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology. 36(1). 142–149. 184 indexed citations

11.

Chitturi, Shivakumar, Geoffrey C. Farrell, Linda Frost, et al.. (2002). Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?. Hepatology. 36(2). 403–409. 293 indexed citations

12.

Hui, Jason M., Jacob George, Christopher Liddle, et al.. (2002). Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance. The American Journal of Gastroenterology. 97(4). 1003–1009. 12 indexed citations

13.

Farrell, Geoffrey C., Karen Byth, Rita Lin, et al.. (2000). Which patients with hepatitis C develop liver complications?. Hepatology. 31(2). 513–520. 135 indexed citations

14.

Samarasinghe, Dev, Michael Tapner, & Geoffrey C. Farrell. (2000). Role of oxidative stress in hypoxia-reoxygenation injury to cultured rat hepatic sinusoidal endothelial cells. Hepatology. 31(1). 160–165. 42 indexed citations

15.

Cassell, Jackie, et al.. (1998). RP59500 (quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium. Journal of Infection. 36(3). 324–327. 5 indexed citations

16.

Samarasinghe, Dev. (1998). Culture of sinusoidal endothelial cells from rat liver. Journal of Gastroenterology and Hepatology. 13(8). 851–854. 2 indexed citations

17.

Samarasinghe, Dev & G C Farrell. (1996). The Central Role of Sinusoidal Endothelial Cells in Hepatic Hypoxia–Reoxygenation Injury in the Rat. Hepatology. 24(5). 1230–1237. 40 indexed citations

18.

Samarasinghe, Dev, et al.. (1995). Endoscopic palliation of oesophageal carcinoma with Atkinson prosthesis. Journal of Gastroenterology and Hepatology. 10(1). 56–59. 9 indexed citations

19.

Samarasinghe, Dev & C Tasman-Jones. (1992). The clinical associations with hepatic steatosis: a retrospective study.. PubMed. 105(928). 57–8. 15 indexed citations

20.

Samarasinghe, Dev, G Nicholson, & I. Hamilton. (1991). Dilation of achalasia in the young: a useful alternative. Gastrointestinal Endoscopy. 37(5). 568–569. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact